Curative Operation of Liver Metastasis Six Months After Total Gastrectomy for Early Small Cell Carcinoma of the Stomach

Kou, Tetsumori; Takayama, Wataru; Nishimori, Takanori; Kakuta, Shinsuke; Yanagibashi, Hiroo; Kobayashi, Susumu; Sugaya, Makoto

doi:10.5833/jjgs.2012.0087

Jpn J Gastroenterol Surg

2013

DOI: 10.5833/jjgs.2012.0087

|View full text |Cite

Curative Operation of Liver Metastasis Six Months After Total Gastrectomy for Early Small Cell Carcinoma of the Stomach

Tetsumori Kou¹,

Wataru Takayama²,

Takanori Nishimori³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2015

2022

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Gastric mixed adenoneuroendocrine carcinoma with thyroid transcription factor-1-positive neuroendocrine component

Yamaguchi

Sato

et al. 2015

Clin J Gastroenterol

View full text Add to dashboard Cite

Small cell carcinoma of the stomach, which is considered synonymous with neuroendocrine carcinoma, is rare. We encountered a case of mixed adenoneuroendocrine carcinoma. Gastrointestinal endoscopy revealed a type 0 IIa + IIc lesion in the stomach. Biopsy suggested well-differentiated adenocarcinoma. Endoscopic submucosal dissection was performed and gastric cancer comprising both well to moderately differentiated adenocarcinoma within the mucous membrane and small cell carcinoma invading to the submucosa with accompanying vessel invasion was found. Mixed adenoneuroendocrine carcinoma was diagnosed and the small cell carcinoma was thyroid transcription factor-1 positive. No tumor lesions were apparent in other organs, so distal gastrectomy and lymph node dissection were performed. Lymph node metastases were not observed. The patient is currently alive without recurrence. Thyroid transcription factor-1-positive gastric neuroendocrine carcinoma is very rare, and the thyroid transcription factor-1-positive rate may contribute to the prediction of prognosis and treatment selection. Accumulation of cases is thus very important.

show abstract

Gastric mixed adenoneuroendocrine carcinoma with thyroid transcription factor-1-positive neuroendocrine component

Yamaguchi

Sato

et al. 2015

Clin J Gastroenterol

View full text Add to dashboard Cite

show abstract

A Case in Which Preoperative Chemotherapy Had a Significant Effect on Stage 4 Small Cell Gastric Carcinoma

Endo

Onoyama

Sha

et al. 2022

Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Curative Operation of Liver Metastasis Six Months After Total Gastrectomy for Early Small Cell Carcinoma of the Stomach

Cited by 2 publications

References 10 publications

Gastric mixed adenoneuroendocrine carcinoma with thyroid transcription factor-1-positive neuroendocrine component

Gastric mixed adenoneuroendocrine carcinoma with thyroid transcription factor-1-positive neuroendocrine component

A Case in Which Preoperative Chemotherapy Had a Significant Effect on Stage 4 Small Cell Gastric Carcinoma

Contact Info

Product

Resources

About